透過您的圖書館登入
IP:3.17.173.165
  • 期刊

慢性C型肝炎患者接受干擾素合併Ribavirin治療的決策過程

The Decision-making Process of Receiving Interferon Plus Ribavirin Therapy for Patients with Chronic Hepatitis C

摘要


本研究目的在探討慢性C型肝炎患者接受干擾素合併ribavirin治療的決策過程,以現象學的研究法自中部某醫學中心訪談十位接受干擾素合併ribavirin治療的慢性C型肝炎患者,以半結構且深入的方式進行訪談,所有訪談內容均予以錄音並轉換成文子。以Giorgi的現象學方法分析所收集的資料,研究結果歸納出三個主要概念會影響其決策過程,包括:(1)治療的動機,(2)資訊的探索,(3)猶豫與決定。藉此深入了解這些個案的治療決策經驗,可做爲護理人員設計合適的諮詢內容與衛教方案。

並列摘要


The purpose of this study was to explore the decision-making process of receiving interferon plus ribavirin therapy for patients with chronic hepatitis C. Ten patients were interviewed by an open-ended, semi-structured, and non-guided questionnaire. The contents of the interview were audio-taped and transcribed. Data were analyzed using Giorgi's phenomenological method. Results were organized into the following three categories: (1) The motivation of treatment, (2) Information seeking process, (3) Hesitation and decision-making. Understanding of the experiences of these patients enables nurses to design appropriate counseling and education programs to meet their needs.

被引用紀錄


張秋純(2009)。不同療程之長效型干擾素合併雷巴威林治療慢性C型肝炎病毒基因型第一型之療效分析〔碩士論文,中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2009.00160
姚遠賢、黃玉苹、楊政議、王守玉(2013)。大腸癌病人決定接受標靶治療之決策過程護理暨健康照護研究9(4),311-319。https://doi.org/10.6225/JNHR.09.4.311

延伸閱讀